vs
Side-by-side financial comparison of STEPAN CO (SCL) and UMB FINANCIAL CORP (UMBF). Click either name above to swap in a different company.
UMB FINANCIAL CORP is the larger business by last-quarter revenue ($739.2M vs $604.5M, roughly 1.2× STEPAN CO). UMB FINANCIAL CORP runs the higher net margin — 35.4% vs 3.3%, a 32.1% gap on every dollar of revenue. On growth, UMB FINANCIAL CORP posted the faster year-over-year revenue change (31.1% vs 1.9%). Over the past eight quarters, UMB FINANCIAL CORP's revenue compounded faster (73.7% CAGR vs 4.2%).
Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.
UMB Financial Corporation is an American financial services company headquartered in Kansas City, Missouri. It offers comprehensive financial services, including deposit solutions like checking and savings accounts, credit services including home mortgages, auto loans, business loans and credit cards, as well as investing and wealth management. UMB serves individuals, companies and institutions across the U.S. and in Ireland.
SCL vs UMBF — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $604.5M | $739.2M |
| Net Profit | $19.7M | $261.4M |
| Gross Margin | 10.7% | — |
| Operating Margin | 4.7% | — |
| Net Margin | 3.3% | 35.4% |
| Revenue YoY | 1.9% | 31.1% |
| Net Profit YoY | — | 221.4% |
| EPS (diluted) | $0.86 | $3.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $604.5M | $739.2M | ||
| Q4 25 | $553.9M | $522.5M | ||
| Q3 25 | $590.3M | $475.0M | ||
| Q2 25 | $594.7M | $467.0M | ||
| Q1 25 | $593.3M | $397.6M | ||
| Q4 24 | $525.6M | $269.0M | ||
| Q3 24 | $546.8M | $247.4M | ||
| Q2 24 | $556.4M | $245.1M |
| Q1 26 | $19.7M | $261.4M | ||
| Q4 25 | $5.0M | $215.4M | ||
| Q3 25 | $10.8M | $188.3M | ||
| Q2 25 | $11.3M | $217.4M | ||
| Q1 25 | $19.7M | $81.3M | ||
| Q4 24 | $3.4M | $120.0M | ||
| Q3 24 | $23.6M | $109.6M | ||
| Q2 24 | $9.5M | $101.3M |
| Q1 26 | 10.7% | — | ||
| Q4 25 | 9.3% | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | 12.1% | — | ||
| Q1 25 | 12.7% | — | ||
| Q4 24 | 10.8% | — | ||
| Q3 24 | 13.8% | — | ||
| Q2 24 | 12.5% | — |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 1.9% | 51.7% | ||
| Q3 25 | 3.7% | 49.8% | ||
| Q2 25 | 3.0% | 58.9% | ||
| Q1 25 | 4.8% | 23.4% | ||
| Q4 24 | 1.5% | 53.8% | ||
| Q3 24 | 4.4% | 54.8% | ||
| Q2 24 | 3.4% | 51.8% |
| Q1 26 | 3.3% | 35.4% | ||
| Q4 25 | 0.9% | 41.2% | ||
| Q3 25 | 1.8% | 39.6% | ||
| Q2 25 | 1.9% | 46.5% | ||
| Q1 25 | 3.3% | 20.5% | ||
| Q4 24 | 0.6% | 44.6% | ||
| Q3 24 | 4.3% | 44.3% | ||
| Q2 24 | 1.7% | 41.3% |
| Q1 26 | $0.86 | $3.35 | ||
| Q4 25 | $0.22 | $2.90 | ||
| Q3 25 | $0.47 | $2.36 | ||
| Q2 25 | $0.50 | $2.82 | ||
| Q1 25 | $0.86 | $1.21 | ||
| Q4 24 | $0.14 | $2.44 | ||
| Q3 24 | $1.03 | $2.23 | ||
| Q2 24 | $0.42 | $2.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $328.4M | $477.2M |
| Stockholders' EquityBook value | $1.2B | $7.8B |
| Total Assets | $2.3B | $72.7B |
| Debt / EquityLower = less leverage | 0.28× | 0.06× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $132.7M | $7.8B | ||
| Q3 25 | $118.5M | $8.8B | ||
| Q2 25 | $88.9M | $11.0B | ||
| Q1 25 | $107.5M | $10.6B | ||
| Q4 24 | $99.7M | $8.4B | ||
| Q3 24 | $147.3M | $7.3B | ||
| Q2 24 | $124.7M | $5.0B |
| Q1 26 | $328.4M | $477.2M | ||
| Q4 25 | $626.7M | $474.2M | ||
| Q3 25 | $655.5M | $471.3M | ||
| Q2 25 | $658.0M | $657.3M | ||
| Q1 25 | $659.3M | $654.4M | ||
| Q4 24 | $625.4M | $385.3M | ||
| Q3 24 | $688.5M | $384.8M | ||
| Q2 24 | $657.1M | $384.2M |
| Q1 26 | $1.2B | $7.8B | ||
| Q4 25 | $1.2B | $7.7B | ||
| Q3 25 | $1.2B | $7.4B | ||
| Q2 25 | $1.2B | $7.3B | ||
| Q1 25 | $1.2B | $6.7B | ||
| Q4 24 | $1.2B | $3.5B | ||
| Q3 24 | $1.2B | $3.5B | ||
| Q2 24 | $1.2B | $3.2B |
| Q1 26 | $2.3B | $72.7B | ||
| Q4 25 | $2.4B | $73.1B | ||
| Q3 25 | $2.4B | $71.9B | ||
| Q2 25 | $2.4B | $71.8B | ||
| Q1 25 | $2.4B | $69.3B | ||
| Q4 24 | $2.3B | $50.4B | ||
| Q3 24 | $2.4B | $47.5B | ||
| Q2 24 | $2.3B | $44.5B |
| Q1 26 | 0.28× | 0.06× | ||
| Q4 25 | 0.50× | 0.06× | ||
| Q3 25 | 0.53× | 0.06× | ||
| Q2 25 | 0.53× | 0.09× | ||
| Q1 25 | 0.55× | 0.10× | ||
| Q4 24 | 0.53× | 0.11× | ||
| Q3 24 | 0.56× | 0.11× | ||
| Q2 24 | 0.55× | 0.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
UMBF
Segment breakdown not available.
